Literature DB >> 11889230

Regional and progressive thinning of the cortical ribbon in Huntington's disease.

H D Rosas1, A K Liu, S Hersch, M Glessner, R J Ferrante, D H Salat, A van der Kouwe, B G Jenkins, A M Dale, B Fischl.   

Abstract

BACKGROUND: Huntington's disease (HD) is a fatal and progressive neurodegenerative disease that is accompanied by involuntary movements, cognitive dysfunction, and psychiatric symptoms. Although progressive striatal degeneration is known to occur, little is known about how the disease affects the cortex, including which cortical regions are affected, how degeneration proceeds, and the relationship of the cortical degeneration to clinical symptoms. The cortex has been difficult to study in neurodegenerative diseases primarily because of its complex folding patterns and regional variability; however, an understanding of how the cortex is affected by the disease may provide important new insights into it.
METHODS: Novel automated surface reconstruction and high-resolution MR images of 11 patients with HD and 13 age-matched subjects were used to obtain cortical thickness measurements. The same analyses were performed on two postmortem brains to validate these methods.
RESULTS: Regionally specific heterogeneous thinning of the cortical ribbon was found in subjects with HD. Thinning occurred early, differed among patients in different clinical stages of disease, and appeared to proceed from posterior to anterior cortical regions with disease progression. The sensorimotor region was statistically most affected. Measurements performed on MR images of autopsy brains analyzed similarly were within 0.25 mm of those obtained using traditional neuropathologic methods and were statistically indistinguishable.
CONCLUSIONS: The authors propose that the cortex degenerates early in disease and that regionally selective cortical degeneration may explain the heterogeneity of clinical expression in HD. These measures might provide a sensitive prospective surrogate marker for clinical trials of neuroprotective medications.

Entities:  

Mesh:

Year:  2002        PMID: 11889230     DOI: 10.1212/wnl.58.5.695

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  403 in total

1.  Comorbidities of obsessive and compulsive symptoms in Huntington's disease.

Authors:  Karen E Anderson; Carissa R Gehl; Karen S Marder; Leigh J Beglinger; Jane S Paulsen
Journal:  J Nerv Ment Dis       Date:  2010-05       Impact factor: 2.254

2.  Normal variation in behavioral adjustment relates to regional differences in cortical thickness in children.

Authors:  Kristine B Walhovd; Christian K Tamnes; Ylba Østby; Paulina Due-Tønnessen; Anders M Fjell
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-02-01       Impact factor: 4.785

3.  Normal age-related brain morphometric changes: nonuniformity across cortical thickness, surface area and gray matter volume?

Authors:  Herve Lemaitre; Aaron L Goldman; Fabio Sambataro; Beth A Verchinski; Andreas Meyer-Lindenberg; Daniel R Weinberger; Venkata S Mattay
Journal:  Neurobiol Aging       Date:  2010-08-23       Impact factor: 4.673

4.  Brain structure in young and old East Asians and Westerners: comparisons of structural volume and cortical thickness.

Authors:  Michael Wei Liang Chee; Hui Zheng; Joshua Oon Soo Goh; Denise Park; Bradley P Sutton
Journal:  J Cogn Neurosci       Date:  2010-04-30       Impact factor: 3.225

5.  Patterns of cortical thinning in relation to event-based prospective memory performance three months after moderate to severe traumatic brain injury in children.

Authors:  Stephen R McCauley; Elisabeth A Wilde; Tricia L Merkley; Kathleen P Schnelle; Erin D Bigler; Jill V Hunter; Zili Chu; Ana C Vásquez; Harvey S Levin
Journal:  Dev Neuropsychol       Date:  2010       Impact factor: 2.253

6.  Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults.

Authors:  Elizabeth C Leritz; David H Salat; Victoria J Williams; David M Schnyer; James L Rudolph; Lewis Lipsitz; Bruce Fischl; Regina E McGlinchey; William P Milberg
Journal:  Neuroimage       Date:  2010-10-28       Impact factor: 6.556

7.  Age-related temporal and parietal cortical thinning in autism spectrum disorders.

Authors:  Gregory L Wallace; Nathan Dankner; Lauren Kenworthy; Jay N Giedd; Alex Martin
Journal:  Brain       Date:  2010-10-05       Impact factor: 13.501

8.  Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.

Authors:  Holly B Kordasiewicz; Lisa M Stanek; Edward V Wancewicz; Curt Mazur; Melissa M McAlonis; Kimberly A Pytel; Jonathan W Artates; Andreas Weiss; Seng H Cheng; Lamya S Shihabuddin; Gene Hung; C Frank Bennett; Don W Cleveland
Journal:  Neuron       Date:  2012-06-21       Impact factor: 17.173

9.  Cerebellum and cognition in multiple sclerosis: the fall status matters.

Authors:  Alon Kalron; Gilles Allali; Anat Achiron
Journal:  J Neurol       Date:  2018-02-02       Impact factor: 4.849

10.  Prefrontal cortical deficits in type 1 diabetes mellitus: brain correlates of comorbid depression.

Authors:  In Kyoon Lyoo; Sujung Yoon; Alan M Jacobson; Jaeuk Hwang; Gail Musen; Jieun E Kim; Donald C Simonson; Sujin Bae; Nicolas Bolo; Dajung J Kim; Katie Weinger; Junghyun H Lee; Christopher M Ryan; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.